Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Jump-Start Your Search For Promising Trade Ideas With Barchart Premier’s "Top Stock Pick". FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | More
 
or
Watchlist | Portfolio
Site News
Contact
Market:

Innocan Pharma Corp (INNPF)

Innocan Pharma Corp (INNPF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Innocan Pharma Initiates FDA Approval Process for Liposome Injection Therapy for Chronic Pain Newswire.ca - Mon Apr 22, 3:01PM CDT

/CNW/ -- Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) ("Innocan" or the "Company"), is pleased to announce that is has reached a key...

INNO.CN : 0.2750 (-3.51%)
INNPF : 0.2081 (-9.95%)
Innocan Pharma Reports Full Year 2023 Results with Revenues up Nearly 6X to $13.7M Newswire.ca - Mon Apr 1, 3:01PM CDT

/CNW/ -- Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTC: INNPF) (the "Company" or "Innocan"), a pharmaceutical technology company focusing on...

INNO.CN : 0.2750 (-3.51%)
INNPF : 0.2081 (-9.95%)
Innocan Pharma paves its way to LPT-CBD Chemistry, Manufacturing and Controls (CMC), key milestones for FDA approval. Newswire.ca - Mon Mar 25, 4:00PM CDT

/CNW/ -- Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) ("Innocan" or the "Company"), a pioneer in the development of drug delivery...

INNO.CN : 0.2750 (-3.51%)
INNPF : 0.2081 (-9.95%)
Innocan Pharma Announces Closing of Private Placement for Gross Proceeds of Approximately C$2 Million Newswire.ca - Thu Mar 14, 7:36PM CDT

/CNW/ -- Innocan Pharma Corporation (the "Company") (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) is pleased to announce that it has closed its previously announced...

INNO.CN : 0.2750 (-3.51%)
INNPF : 0.2081 (-9.95%)
Innocan Pharma's LPT-CBD Has the Potential to Support a new Therapeutic Venue for Neurological Disorders According to Recent Study Newswire.ca - Tue Mar 5, 3:01PM CST

/CNW/ -- Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) ("Innocan" or the "Company"), a pioneer in the development of drug delivery...

INNO.CN : 0.2750 (-3.51%)
INNPF : 0.2081 (-9.95%)
Innocan Pharma Announces Study Findings that LPT-CBD maintains its prolonged release in Rabbits Newswire.ca - Mon Feb 26, 3:00PM CST

/CNW/ -- Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) ("Innocan" or the "Company"), a pioneer in the pharmaceutical and biotechnology...

INNO.CN : 0.2750 (-3.51%)
INNPF : 0.2081 (-9.95%)
Innocan Pharma to participate in the White Label World Expo on February 27-28th, 2024 Newswire.ca - Tue Feb 20, 1:00AM CST

/CNW/ -- Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTC: INNPF) (the "Company" or "Innocan"), is pleased to announce that CEO Iris Bincovich will be a...

BABA : 74.63 (+2.92%)
INNO.CN : 0.2750 (-3.51%)
INNPF : 0.2081 (-9.95%)
Innocan Provides Corporate Update & Preliminary Q4 and Fiscal Year 2023 Financial Highlights Newswire.ca - Tue Feb 13, 12:57AM CST

/CNW/ -- Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTC: INNPF) (the "Company" or "Innocan"), is pleased to provide the following corporate update:...

INNO.CN : 0.2750 (-3.51%)
INNPF : 0.2081 (-9.95%)
Innocan Pharma Announces Expert Team for LPT CBD Application to United States Food and Drug Administration Newswire.ca - Tue Dec 12, 2023

/CNW/ -- Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) (the "Company" or "Innocan") a pioneer in the pharmaceutical and biotechnology...

INNO.CN : 0.2750 (-3.51%)
INNPF : 0.2081 (-9.95%)
Innocan Pharma Reports Q3 2023 Results Including US$3.334M Increase in Revenues Compared to Q3, 2022 Newswire.ca - Wed Nov 29, 2023

/CNW/ -- Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTC: INNPF) (the "Company" or "Innocan"), a pharmaceutical technology company focusing on...

INNO.CN : 0.2750 (-3.51%)
INNPF : 0.2081 (-9.95%)

Barchart Exclusives

3 Dividend Aristocrats to Buy on Every Dip Barchart - Wed Apr 24, 6:30PM CDT
As markets get wobbly, here are three Dividend Aristocrats to add a little stability to any portfolio. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot